Inventor
SING-YUEN SIT
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds24%
C07BGeneral methods of organic chemistry10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
C07CAcyclic or carbocyclic compounds5%
C07JSteroids5%
PatentTitleYear
12,275,721Indazole carboxamides as kinase inhibitors202512,172,9751H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)202412,157,733Aminotriazolopyridines as kinase inhibitors202411,618,753Aminopyrrolotriazines as kinase inhibitors202311,464,790Triterpenoids with HIV maturation inhibitory activity2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to VIIV HEALTHCARE UK NO 4 LTD (1)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to BRISTOL MYERS SQUIBB CO (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 4 | 2023–2025 |
| VIIV HEALTHCARE UK NO 4 LTD | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |